NextCure (NXTC) Cash from Investing Activities (2018 - 2026)

NextCure's Cash from Investing Activities history runs 9 years deep, the most recent figure standing at $1.3 million for Q1 2026.

• In Q1 2026, Cash from Investing Activities fell 81.67% year-over-year to $1.3 million; the TTM figure through Mar 2026 stood at $19.8 million (down 55.61% YoY), while the FY2025 annual figure was $25.6 million, down 53.79% from the prior year.
• Cash from Investing Activities for Q1 2026 stood at $1.3 million, down from $6.0 million in the prior quarter.
• The five-year high for Cash from Investing Activities was $31.9 million in Q2 2022, with the low at $1.3 million in Q1 2026.
• The 5-year median for Cash from Investing Activities is $8.7 million (2025), against an average of $11.1 million.
• The sharpest annual moves came in 2022 and 2026: Cash from Investing Activities jumped 140.61% in 2022, then plunged 81.67% in 2026.
• NextCure's Cash from Investing Activities stood at $4.5 million in 2022, then fell by 6.85% to $4.2 million in 2023, then jumped by 67.18% to $7.0 million in 2024, then slipped by 13.73% to $6.0 million in 2025, then tumbled by 78.34% to $1.3 million in 2026.
• Business Quant data shows NXTC's Cash from Investing Activities at $1.3 million in Q1 2026, $6.0 million in Q4 2025, and $8.7 million in Q3 2025.